GREEN CROSS WellBeing Corporation Logo

GREEN CROSS WellBeing Corporation

Develops nutritional injections, health supplements, and cosmetics.

234690 | KO

Overview

Corporate Details

ISIN(s):
KR7234690006
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 파크원타워2 33층, 서울특별시

Description

GREEN CROSS WellBeing Corporation is a company focused on promoting human health through personalized nutrition solutions. Its primary business areas include the development and manufacturing of prescription nutritional injections, such as its placental injection Laennec. The company also provides a range of health functional foods and supplements, including the Dr. PNT brand, which offers customized nutrient solutions based on individual health needs and expert consultation. Further product lines include cosmetics derived from proprietary cell culture technology. Research and development is a key focus, with active programs in customized probiotics tailored to different life stages, the discovery of new functional materials from natural products, and the development of novel pharmaceutical treatments for conditions such as Cancer Cachexia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-10 00:00
의결권대리행사권유참고서류
Korean 168.6 KB
2025-02-20 00:00
주식등의대량보유상황보고서(일반)
Korean 93.4 KB
2025-02-14 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-02-12 00:00
주요사항보고서(전환사채권발행결정)
Korean 67.6 KB
2025-02-12 00:00
타법인주식및출자증권취득결정
Korean 27.1 KB
2025-02-10 00:00
주주총회소집결의
Korean 12.3 KB
2025-02-10 00:00
현금ㆍ현물배당결정
Korean 9.1 KB
2025-01-31 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-01-31 00:00
[기재정정]연결재무제표기준영업(잠정)실적(공정공시)
Korean 22.9 KB
2024-12-03 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.7 KB
2024-12-03 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.5 MB
2024-11-01 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.5 MB
2024-08-05 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.6 KB

Automate Your Workflow. Get a real-time feed of all GREEN CROSS WellBeing Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GREEN CROSS WellBeing Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GREEN CROSS WellBeing Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.